Immune history profoundly affects broadly protective B cell responses to influenza

Science Translational Medicine

Volumn 7, Issue 316, 2015, Pages

  Andrews, Sarah F ^a   Huang, Yunping ^a   Kaur, Kaval ^a,b   Popova, Lyubov I ^a   Ho, Irvin Y ^a   Pauli, Noel T ^a,b   Dunand, Carole J Henry ^a   Taylor, William M ^a   Lim, Samuel ^a   Huang, Min ^a   Qu, Xinyan ^a   Lee, Jane Hwei ^a   Salgado Ferrer, Marlene ^a   Krammer, Florian ^c   Palese, Peter ^c   Wrammert, Jens ^d   Ahmed, Rafi ^d   Wilson, Patrick C ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INFLUENZA VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MEMORY; INFLUENZA; NORMAL HUMAN; OBSERVATIONAL STUDY; PANDEMIC; PLASMABLAST; PRIORITY JOURNAL; REVACCINATION; SEROLOGY; VIRUS STRAIN; AMINO ACID SEQUENCE; ANIMAL; B LYMPHOCYTE; BLOOD; CELL SEPARATION; CYTOLOGY; DOG; FEMALE; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); MALE; MDCK CELL LINE; MIDDLE AGED; MOLECULAR GENETICS; MONONUCLEAR CELL; PHYLOGENY; SURFACE PLASMON RESONANCE; VIROLOGY;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CELL SEPARATION; DOGS; EPITOPES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; MADIN DARBY CANINE KIDNEY CELLS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; SURFACE PLASMON RESONANCE;

EID: 84954245342     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad0522     Document Type: Article

References (53)

1. J. Wrammert, D. Koutsonanos, G.-M. Li, S. Edupuganti, J. Sui, M. Morrissey, M. McCausland, I. Skountzou, M. Hornig, W. I. Lipkin, A. Mehta, B. Razavi, C. Del Rio, N.-Y. Zheng, J.-H. Lee, M. Huang, Z. Ali, K. Kaur, S. Andrews, R. R. Amara, Y. Wang, S. R. Das, C. D. O'Donnell, J. W. Yewdell, K. Subbarao, W. A. Marasco, M. J. Mulligan, R. Compans, R. Ahmed, P. C. Wilson, Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181-193 (2011).
2. N. Pica, R. Hai, F. Krammer, T. T. Wang, J. Maamary, D. Eggink, G. S. Tan, J. C. Krause, T. Moran, C. R. Stein, D. Banach, J. Wrammert, R. B. Belshe, A. García-Sastre, P. Palese, Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. U.S.A. 109, 2573-2578 (2012).
3. G.-M. Li, C. Chiu, J. Wrammert, M. McCausland, S. F. Andrews, N.-Y. Zheng, J.-H. Lee, M. Huang, X. Qu, S. Edupuganti, M. Mulligan, S. R. Das, J. W. Yewdell, A. K. Mehta, P. C. Wilson, R. Ahmed, Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. U.S.A. 109, 9047-9052 (2012).
4. C. A. Thomson, Y. Wang, L. M. Jackson, M. Olson, W. Wang, A. Liavonchanka, L. Keleta, V. Silva, S. Diederich, R. B. Jones, J. Gubbay, J. Pasick, M. Petric, F. Jean, V. G. Allen, E. G. Brown, J.M. Rini, J. W. Schrader, Pandemic H1N1 influenza infection and vaccination in humans induces crossprotective antibodies that target the hemagglutinin stem. Front. Immunol. 3, 87 (2012).
5. M. Y. Sangster, J. Baer, F. W. Santiago, T. Fitzgerald, N. A. Ilyushina, A. Sundararajan, A. D. Henn, F. Krammer,H. Yang, C. J. Luke,M. S. Zand, P. F. Wright, J. J. Treanor, D. J. Topham, K. Subbarao, B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination. Clin. Vaccine Immunol. 20, 867-876 (2013).
6. D. C. Ekiert, G. Bhabha, M.-A. Elsliger, R.H. E. Friesen,M. Jongeneelen, M. Throsby, J. Goudsmit, I. A. Wilson, Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251 (2009).
7. J. Sui, W. C. Hwang, S. Perez, G. Wei, D. Aird, L.-M. Chen, E. Santelli, B. Stec, G. Cadwell, M. Ali, H. Wan, A. Murakami, A. Yammanuru, T. Han, N. J. Cox, L. A. Bankston, R. O. Donis, R. C. Liddington, W. A. Marasco, Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273 (2009).
8. D. Corti, A. L. Suguitan Jr., D. Pinna, C. Silacci, B. M. Fernandez-Rodriguez, F. Vanzetta, C. Santos, C. J. Luke, F. J. Torres-Velez, N. J. Temperton, R. A. Weiss, F. Sallusto, K. Subbarao, A. Lanzavecchia, Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 120, 1663-1673 (2010).
9. F. Krammer, P. Palese, Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr. Opin. Virol. 3, 521-530 (2013).
10. G. A. Kirchenbaum, T. M. Ross, Eliciting broadly protective antibody responses against influenza. Curr. Opin. Immunol. 28, 71-76 (2014).
11. V. Pascual, Y.-J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, J. D. Capra, Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp. Med. 180, 329-339 (1994).
12. J. Wrammert, K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N.-Y. Zheng, I. Mays, L. Garman, C. Helms, J. James, G. M. Air, J. D. Capra, R. Ahmed, P. C. Wilson, Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667-671 (2008).
13. K. Smith, L. Garman, J. Wrammert, N.-Y. Zheng, J. D. Capra, R. Ahmed, P. C. Wilson, Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372-384 (2009).
14. C. Dreyfus, N. S. Laursen, T. Kwaks, D. Zuijdgeest, R. Khayat, D. C. Ekiert, J. H. Lee, Z. Metlagel, M. V. Bujny,M. Jongeneelen, R. van der Vlugt, M. Lamrani, H. J. W. M. Korse, E. Geelen, Ö. Sahin, M. Sieuwerts, J. P. J. Brakenhoff, R. Vogels, O. T. W. Li, L. L. M. Poon, M. Peiris, W. Koudstaal, A. B. Ward, I. A. Wilson, J. Goudsmit, R. H. E. Friesen, Highly conserved protective epitopes on influenza B viruses. Science 337, 1343-1348 (2012).
15. D. Corti, J. Voss, S. J. Gamblin, G. Codoni, A. Macagno, D. Jarrossay, S. G. Vachieri, D. Pinna, A. Minola, F. Vanzetta, C. Silacci, B. M. Fernandez-Rodriguez, G. Agatic, S. Bianchi, I. Giacchetto-Sasselli, L. Calder, F. Sallusto, P. Collins, L. F. Haire, N. Temperton, J. P. M. Langedijk, J. J. Skehel, A. Lanzavecchia, A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856 (2011).
16. C. J. Henry Dunand, P. E. Leon, K. Kaur, G. S. Tan, N.-Y. Zheng, S. Andrews, M. Huang, X. Qu, Y. Huang, M. Salgado-Ferrer, I. Y. Ho, W. Taylor, R. Hai, J. Wrammert, R. Ahmed, A. García-Sastre, P. Palese, F. Krammer, P. C. Wilson, Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J. Clin. Invest. 125, 1255-1268 (2015).
17. J. Steel, A. C. Lowen, T. T. Wang, M. Yondola, Q. Gao, K. Haye, A. García-Sastre, P. Palese, Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1, e00018-10 (2010).
18. P. N. Graves, J. L. Schulman, J. F. Young, P. Palese, Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: Unmasking of cross-reactive HA2 determinants. Virology 126, 106-116 (1983).
19. Y. Avnir, A. S. Tallarico, Q. Zhu, A. S. Bennett, G. Connelly, J. Sheehan, J. Sui, A. Fahmy, C.-. Huang, G. Cadwell, L. A. Bankston, A. T. McGuire, L. Stamatatos, G. Wagner, R. C. Liddington, W. A. Marasco, Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses. PLOS Pathog. 10, e1004103 (2014).
20. A. K. Harris, J. R. Meyerson, Y. Matsuoka, O. Kuybeda, A. Moran, D. Bliss, S. R. Das, J. W. Yewdell, G. Sapiro, K. Subbarao, S. Subramaniam, Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies. Proc. Natl. Acad. Sci. U.S.A. 110, 4592-4597 (2013).
21. R. Hai, F. Krammer, G. S. Tan, N. Pica, D. Eggink, J. Maamary, I. Margine, R. A. Albrecht, P. Palese, Influenza viruses expressing chimeric hemagglutinins: Globular head and stalk domains derived from different subtypes. J. Virol. 86, 5774-5781 (2012).
22. K. Kaur, M. Sullivan, P. C. Wilson, Targeting B cell responses in universal influenza vaccine design. Trends Immunol. 32, 524-531 (2011).
23. D. Lingwood, P.M. McTamney, H. M. Yassine, J. R. R. Whittle, X. Guo, J. C. Boyington, C.-J. Wei, G. J. Nabel, Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489, 566-570 (2012).
24. T. Tiller, M. Tsuiji, S. Yurasov, K. Velinzon, M. C. Nussenzweig, H. Wardemann, Autoreactivity in human IgG+ memory B cells. Immunity 26, 205-213 (2007).
25. K. Koelsch, N.-Y. Zheng, Q. Zhang, A. Duty, C. Helms, M. D. Mathias, M. Jared, K. Smith, J. D. Capra, P. C. Wilson, Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest. 117, 1558-1565 (2007).
26. M. Z. Radic, M. Weigert, Intricacies of anti-DNA autoantibodies. J. Immunol. 172, 3367-3368 (2004).
27. H. Mouquet, J. F. Scheid, M. J. Zoller, M. Krogsgaard, R. G. Ott, S. Shukair, M. N. Artyomov, J. Pietzsch, M. Connors, F. Pereyra, B. D. Walker, D. D. Ho, P. C. Wilson, M. S. Seaman, H. N. Eisen, A. K. Chakraborty, T. J. Hope, J. V. Ravetch, H. Wardemann, M. C. Nussenzweig, Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467, 591-595 (2010).
28. D. Gay, T. Saunders, S. Camper, M. Weigert, Receptor editing: An approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999-1008 (1993).
29. K. Hancock, V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, T. L. Brammer, N. J. Cox, T. M. Tumpey, J. M. Katz, Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945-1952 (2009).
30. E. Miller, K. Hoschler, P. Hardelid, E. Stanford, N. Andrews, M. Zambon, Incidence of 2009 pandemic influenza A H1N1 infection in England: A cross-sectional serological study. Lancet 375, 1100-1108 (2010).
31. M. S. Miller, T. Tsibane, F. Krammer, R. Hai, S. Rahmat, C. F. Basler, P. Palese, 1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans. J. Infect. Dis. 207, 98-105 (2013).
32. T. M. Ross, C. J. Lin, M. P. Nowalk, H.-H. Huang, S. M. Spencer, D. K. Shay, S. Sambhara, M. E. Sundaram, T. Friedrich, S. Sauereisen, C. E. Bloom, R. K. Zimmerman, Influence of preexisting hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age. Hum. Vaccin. Immunother. 10, 1195-1203 (2014).
33. D. M. Carter, H.-R. Lu, C. E. Bloom, C. J. Crevar, J. L. Cherry, D. J. Lipman, T. M. Ross, Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains. PLOS One 7, e39435 (2012).
34. D. M. Carter, C. E. Bloom, E. J. M. Nascimento, E. T. A. Marques, J. K. Craigo, J. L. Cherry, D. J. Lipman, T. M. Ross, Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J. Virol. 87, 1400-1410 (2013).
35. Y. Li, J. L. Myers, D. L. Bostick, C. B. Sullivan, J. Madara, S. L. Linderman, Q. Liu, D. M. Carter, J. Wrammert, S. Esposito, N. Principi, J. B. Plotkin, T.M. Ross, R. Ahmed, P. C. Wilson, S. E. Hensley, Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J. Exp. Med. 210, 1493-1500 (2013).
36. A. H. Ellebedy, F. Krammer, G.-M. Li, M. S. Miller, C. Chiu, J. Wrammert, C. Y. Chang, C. W. Davis, M. McCausland, R. Elbein, S. Edupuganti, P. Spearman, S. F. Andrews, P. C. Wilson, A. García-Sastre, M. J. Mulligan, A. K. Mehta, P. Palese, R. Ahmed, Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc. Natl. Acad. Sci. U.S.A. 111, 13133-13138 (2014).
37. P. S. Lee, I. A. Wilson, Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr. Top. Microbiol. Immunol. 386, 323-341 (2015).
38. L. Pappas, M. Foglierini, L. Piccoli, N. L. Kallewaard, F. Turrini, C. Silacci, B. Fernandez-Rodriguez, G. Agatic, I. Giacchetto-Sasselli, G. Pellicciotta, F. Sallusto, Q. Zhu, E. Vicenzi, D. Corti, A. Lanzavecchia, Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418-422 (2014).
39. H. Wardemann, S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, M. C. Nussenzweig, Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
40. I. Isnardi, Y.-S. Ng, L. Menard, G. Meyers, D. Saadoun, I. Srdanovic, J. Samuels, J. Berman, J. H. Buckner, C. Cunningham-Rundles, E. Meffre, Complement receptor 2/CD21- human naive B cells mostly contain autoreactive unresponsive clones. Blood 115, 5026-5036 (2010).
41. J. A. Duty, P. Szodoray, N.-Y. Zheng, K. A. Koelsch, Q. Zhang, M. Swiatkowski, M. Mathias, L. Garman, C. Helms, B. Nakken, K. Smith, A. D. Farris, P. C. Wilson, Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J. Exp. Med. 206, 139-151 (2009).
42. J. Zikherman, R. Parameswaran, A. Weiss, Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 489, 160-164 (2012).
43. C. C. Goodnow, J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, R. J. Trent, A. Basten, Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676-682 (1988).
44. J. J. Otterstrom, B. Brandenburg, M. H. Koldijk, J. Juraszek, C. Tang, S. Mashaghi, T. Kwaks, J. Goudsmit, R. Vogels, R. H. E. Friesen, A. M. van Oijen, Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level. Proc. Natl. Acad. Sci. U.S.A. 111, E5143-E5148 (2014).
45. F. Krammer, N. Pica, R. Hai, I. Margine, P. Palese, Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J. Virol. 87, 6542-6550 (2013).
46. F. Krammer, R. Hai, M. Yondola, G. S. Tan, V. H. Leyva-Grado, A. B. Ryder, M. S. Miller, J. K. Rose, P. Palese, A. García-Sastre, R. A. Albrecht, Assessment of influenza virus hemagglutinin stalkbased immunity in ferrets. J. Virol. 88, 3432-3442 (2014).
47. F. Krammer, I. Margine, R. Hai, A. Flood, A. Hirsh, V. Tsvetnitsky, D. Chen, P. Palese, H3 stalkbased chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J. Virol. 88, 2340-2343 (2014).
48. K. Kaur, N.-Y. Zheng, K. Smith, M. Huang, L. Li, N. T. Pauli, C. J. Henry Dunand, J.-H. Lee, M. Morrissey, Y. Wu, M. L. Joachims, M. E. Munroe, D. Lau, X. Qu, F. Krammer, J. Wrammert, P. Palese, R. Ahmed, J. A. James, P. C. Wilson, High affinity antibodies against influenza characterize the plasmablast response in SLE patients after vaccination. PLOS One 10, e0125618 (2015).
49. J. R. R. Whittle, A. K. Wheatley, L. Wu, D. Lingwood, M. Kanekiyo, S. S. Ma, S. R. Narpala, H. M. Yassine, G. M. Frank, J. W. Yewdell, J. E. Ledgerwood, C.-J. Wei, A. B. McDermott, B. S. Graham, R. A. Koup, G. J. Nabel, Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88, 4047-4057 (2014).
50. M. M. Souto-Carneiro, N. S. Longo, D. E. Russ, H.-. Sun, P. E. Lipsky, Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol. 172, 6790-6802 (2004).
51. M.-P. Lefranc, V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, L. Regnier, F. Ehrenmann, G. Lefranc, P. Duroux, IMGT®, the international ImMunoGeneTics information system®. Nucleic Acids Res. 37, D1006-D1012 (2009).
52. F. Sievers, A. Wilm, D. Dineen, T. J. Gibson, K. Karplus, W. Li, R. Lopez, H. McWilliam, M. Remmert, J. Söding, J. D. Thompson, D. G. Higgins, Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).
53. I. Margine, P. Palese, F. Krammer, Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Vis. Exp. e51112 (2013).